Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · IEX Real-Time Price · USD
25.19
-0.13 (-0.51%)
At close: Mar 28, 2024, 4:00 PM
24.12
-1.07 (-4.25%)
After-hours: Mar 28, 2024, 6:16 PM EDT

Corcept Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2001
Net Income
105.5101.29112.51106.0194.1875.41129.128.14-6.41-31.38
Upgrade
Depreciation & Amortization
2.363.453.482.242.170.240.110.090.160.14
Upgrade
Share-Based Compensation
48.9442.4442.9333.5429.3123.7513.657.066.015.2
Upgrade
Other Operating Activities
-29.76-26.858.9710.1810.4516.27-81.953.113.37-1.34
Upgrade
Operating Cash Flow
127.04120.32167.89151.97136.12115.6760.9418.393.13-27.38
Upgrade
Operating Cash Flow Growth
5.58%-28.33%10.48%11.65%17.68%89.82%231.33%487.57%--
Upgrade
Capital Expenditures
-0.14-0.41-0.47-1.24-1.09-0.3-0.42-0.19-0.02-0.17
Upgrade
Change in Investments
91.05-113.91136.6-118.03-116.74-90.47-73.04000
Upgrade
Investing Cash Flow
90.91-114.33136.13-119.26-117.83-90.77-73.46-0.19-0.02-0.17
Upgrade
Share Issuance / Repurchase
-148.72-17.28-302.5912.21-28.65-14.347.187.6822.281.78
Upgrade
Debt Issued / Paid
000000-15.13-14.78-9.21-4.86
Upgrade
Financing Cash Flow
-148.72-17.28-302.5912.21-28.65-14.34-7.95-7.113.07-3.08
Upgrade
Net Cash Flow
69.22-11.291.4344.92-10.3610.56-20.4711.116.19-30.63
Upgrade
Free Cash Flow
126.9119.91167.42150.73135.03115.3760.5218.23.11-27.55
Upgrade
Free Cash Flow Growth
5.83%-28.38%11.07%11.63%17.04%90.64%232.56%484.55%--
Upgrade
Free Cash Flow Margin
26.31%29.84%45.75%42.59%44.06%45.92%38.01%22.38%6.19%-103.76%
Upgrade
Free Cash Flow Per Share
1.231.121.451.311.181.000.530.170.03-0.27
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).